ClinConnect ClinConnect Logo
Search / Trial NCT05996172

Swift Outpatient Alternatives for Rapid Stabilization

Launched by UNIVERSITY OF WASHINGTON · Aug 15, 2023

Trial Information

Current as of November 14, 2025

Recruiting

Keywords

ClinConnect Summary

The Swift Outpatient Alternatives for Rapid Stabilization (SOARS) trial is a research study aimed at helping young people who are experiencing thoughts of suicide or have recently attempted suicide. The main goal of this trial is to find the best combination of support services that can effectively reduce these thoughts and behaviors in youth. The study will look at how different factors, like the age of the participants and their history with suicidal thoughts, can influence the success of the interventions. It will also explore how well medical providers manage referrals to the SOARS program and ensure continued care afterward.

To be eligible for the trial, participants must be between the ages of 12 and 18 and currently experiencing acute suicidal thoughts or have attempted suicide within the last month. Some individuals may not qualify if they need immediate medical care, have certain mental health conditions, or if they or their caregivers cannot participate in the therapy. If someone joins the study, they can expect to receive tailored support aimed at improving their mental health, along with ongoing assessments to track their progress. This trial is currently recruiting participants and aims to create a better, more effective approach to managing youth suicide risk in outpatient settings.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Acute suicidal thoughts or past month suicide attempt as reported on positive responses to the Ask Suicide Screening Questionnaire (ASQ),
  • Exclusion Criteria:
  • urgent medical care secondary to self-injurious behavior, psychosis, eating disorder that requires full or partial inpatient care, or
  • intellectual disability warranting a different treatment pathway;
  • limited English, Spanish, Vietnamese, or Chinese proficiency that would interfere with ability to complete study assessments;
  • unwillingness to participate in psychotherapy,
  • caregiver unwilling or ineligible to participate;
  • and previous enrollment in SOARS program or other P50 project as to not confuse longitudinal follow-up.

About University Of Washington

The University of Washington (UW) is a leading academic institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a robust network of interdisciplinary teams, UW fosters collaboration among top-tier researchers, clinicians, and healthcare professionals, aiming to translate scientific discoveries into impactful treatments and interventions. The university is dedicated to ethical research practices and participant safety, ensuring rigorous adherence to regulatory standards in all clinical trials. Through its state-of-the-art facilities and extensive expertise, UW strives to address pressing health challenges and improve patient outcomes on a local and global scale.

Locations

Seattle, Washington, United States

Patients applied

0 patients applied

Trial Officials

Molly Adrian, Ph.D.

Principal Investigator

University of Washington

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported